DocSym
β
Searchsearch
Search
(C91.2) Подострый лимфоцитарный лейкоз
More details coming soon
3 154 888 in individuals diagnosis подострый лимфоцитарный лейкоз confirmed
327 047 deaths with diagnosis подострый лимфоцитарный лейкоз
10% mortality rate associated with the disease подострый лимфоцитарный лейкоз
Diagnosis подострый лимфоцитарный лейкоз is diagnosed Men are 26.01% more likely than Women
1 987 810
Men receive the diagnosis подострый лимфоцитарный лейкоз
191 842 (9.7 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 167 078
Women receive the diagnosis подострый лимфоцитарный лейкоз
135 205 (11.6 %)Died from this diagnosis.
Risk Group for the Disease подострый лимфоцитарный лейкоз - Men aged 60-64 and Women aged 65-69
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features подострый лимфоцитарный лейкоз
Absence or low individual and public risk
Подострый лимфоцитарный лейкоз - what does this mean
Subacute lymphocytic leukemia (sll) is a type of cancer of the blood and bone marrow that is caused by an overproduction of abnormal b-cells, which are a type of white blood cell. it is characterized by an accumulation of these cells in the blood, bone marrow, and other organs, leading to a decrease in the production of healthy white and red blood cells and platelets, and ultimately anemia, infections, and bleeding.
What happens during the disease - подострый лимфоцитарный лейкоз
More details coming soon
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete Blood Count (CBC)
- Bone Marrow Biopsy
- Flow Cytometry
- Cytogenetic Analysis
- Immunophenotyping
- Molecular Genetic Testing
- Lymph Node Biopsy
Treatment and Medical Assistance
Main goal of the treatment: To reduce the number of lymphocytes in the blood and reduce the symptoms of the disease.
- Prescribe medications to reduce the number of lymphocytes in the blood.
- Provide advice on lifestyle changes to help reduce symptoms.
- Provide advice on dietary changes to help reduce symptoms.
- Provide advice on stress management to help reduce symptoms.
- Monitor the patient's condition and adjust medications as necessary.
- Refer the patient to a specialist if necessary.
- Monitor the patient's response to treatment and make necessary adjustments.
16 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Подострый лимфоцитарный лейкоз - Prevention
More details coming soon